Sdi Limited · ASX:SDI
Sdi — Shareholder Meeting (November 2022)
13 slides from Sdi's shareholder meeting presentation, Nov 24, 2022
Slide 1: FY22 AGM
FY22 AGM NOVEMBER 24, 2022
Slide 2: Chairman's Address
CHAIRMAN’S ADDRESS JEFFERY CHEETHAM
Slide 3: CEO's Address
CEO’S ADDRESS SAMANTHA CHEETHAM
Slide 4: FY22 Highlights
FY22 HIGHLIGHTS RECORD SALES WITH STRONG PERFORMANCE ACROSS KEY PRODUCT CATEGORIES Sales ($m) o Record sales of $95.2m, up 16.5%, with growth in all key product 74.5 79.6 81.6 95.2 categories and in most regions. 74.1 67.4 48.9 o Freight costs up $3.3million impacting product margins by 3.8% 39.7 40
Slide 5: FY22 Category Overview
FY22 CATEGORY OVERVIEW DOUBLE DIGIT CAGR IN KEY FOCUS PRODUCTS o Aesthetics and Whitening sales up 17.2% Product category Change in local Change in AUD Total AUD sales and 12.9%, respectively, from market share sales currency % % % gains and momentum in new product releases Aesthetics 17.2 17.6 45.3
Slide 6: FY22 Sales by Business Unit
FY22 SALES BY BUSINESS UNIT RETURNING TO NORMAL OPERATING CONDITIONS o European sales up 21.7%, in local currency, Growth in local Growth in AUD Total AUD from strong demand in key markets and Sales by Business Unit currency % % Sales % improved conditions in the UK Australian sales (including 15.8
Slide 7: Operational Update
OPERATIONAL UPDATE PURCHASE OF NEW SITE TO SUPPORT LONG TERM STRATEGIC PLAN o SDI confirmed the purchase of a 6-acre site to support the long- term strategic plan for the group. In the short-term, the site will also provide important warehousing capacity o Following renovation work on the warehouse,
Slide 8: Amalgam Replacement
AMALGAM REPLACEMENT STELA RECEIVES FDA APPROVAL o Amalgam replacement release in all markets during 2023 o FDA approval received o Tooth coloured filling, showing strength stronger than amalgam o Stronger than any other tooth coloured filling material o Will be able to withstand high mastication for
Slide 9: Trading Update
TRADING UPDATE o Sales in the first 4 Months of FY23 up 11.6% in local currencies. • Biggest contribution from Aesthetics and Amalgam product categories. • Australian direct exports up 19.7%. • Australian domestic up 33.5%. • Brazilian sales up 14.0%. • European sales up 4.1%. • North American sales
Slide 10: Strategy
STRATEGY o Aesthetics and Whitening products continue to be the focus for new product development; o Achieving manufacturing efficiencies and driving sales and marketing teams o On-going investment in R&D to release 1-2 products per year is on target o SDI’s amalgam replacement product Stela secures
Slide 11: Outlook
OUTLOOK o Future years expected to show continued growth in Aesthetics and Whitening products, underpinned by improving market conditions and new product development o Amalgam category to remain strong short-term as competitors leave the category and industry begins transition to replacement product
Slide 12: Questions
QUESTIONS
Slide 13: Disclaimer
Disclaimer This Presentation contains summary information about SDI Limited (SDI) and its subsidiaries and their activities. The information in this Presentation does not purport to be complete. It should be read in conjunction with SDI’s other periodic and continuous disclosure announcements lodged